MyFinsight
Home
Blog
About
Contact
Download
Download image
Net decrease in
cash, cash...
-$5,775K
Grant receivables
-$6,266K
Equity-based compensation
$330K
Prepaid expenses and
other assets
-$136K
Amortization of right-of-use
assets
$57K
Depreciation and
amortization
$11K
Realized loss on disposal
of property and...
-$5K
Proceeds from the
exercise of common stock...
$44K
Net cash used in
operating activities
-$5,542K
Net cash provided
(used) by financing...
-$233K
Canceled cashflow
$6,805K
Canceled cashflow
$44K
Grant income
$3,979K
Other segment items
-$268K
Accounts payable and
accrued expenses
-$7,570K
Payment of employee
withholding taxes on vested...
$164K
Payments on loan payable
$113K
Net loss
-$4,570K
Deferred grant income and
other liabilities
-$147K
Operating lease
liabilities
-$60K
Canceled cashflow
$4,247K
Clinical programs
$3,381K
General and
administrative expenses
$2,505K
R&d personnel costs
$1,594K
Preclinical programs
$619K
Manufacturing
$337K
Equity-based compensation
$330K
Other research and
development expenses
$51K
Back
Back
Cash Flow
COGNITION THERAPEUTICS INC (CGTX)
COGNITION THERAPEUTICS INC (CGTX)
source: myfinsight.com